Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Solubility: DMSO: 105
Poliumoside exhibits significant inhibition of advanced glycation end product formation with IC50 values of 19
PubMed PMID: 21677062
GSK2256098 inhibits FAK activity or Y397 phosphorylation in cancer cell lines
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
Hydroxyurea Size:Solid 2 mg Solubility: DMSO: 105Hydroxyurea is a fetal hemoglobin stimulator and ribonucleotide reductase inhibitor used to treat sickle cell anemia, myeloproliferative disorders, and leukemias. It decreases the production of deoxyribonucleotides and also increases levels of NO in the blood. Product information CAS Number: 127 07 1 Molecular Weight: 76. 05 Formula: CH4N2O2 Chemical Name: hydroxyurea Smiles: NC(=O)NO InChiKey: VSNHCAURESNICA UHFFFAOYSA N InChi: InChI=1S CH4N2O2 c2